Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei 10617, Taiwan.
Molecules. 2020 Nov 3;25(21):5114. doi: 10.3390/molecules25215114.
(1) Background: Few antifungal drugs are currently available, and drug-resistant strains have rapidly emerged. Thus, the aim of this study is to evaluate the effectiveness of the antifungal activity from a combinational treatment of chitosan with a clinical antifungal drug on Candida albicans and Candida tropicalis. (2) Methods: Minimum inhibitory concentration (MIC) tests, checkerboard assays, and disc assays were employed to determine the inhibitory effect of chitosan with or without other antifungal drugs on and . (3) Results: Treatment with chitosan in combination with fluconazole showed a great synergistic fungicidal effect against and , but an indifferent effect on antifungal activity when challenged with chitosan-amphotericin B or chitosan-caspofungin simultaneously. Furthermore, the combination of chitosan and fluconazole was effective against drug-resistant strains. (4) Conclusions: These findings provide strong evidence that chitosan in combination with fluconazole is a promising therapy against two species and its drug-resistant strains.
(1)背景:目前可用的抗真菌药物很少,而且耐药菌株迅速出现。因此,本研究旨在评估壳聚糖与临床抗真菌药物联合治疗对白色念珠菌和热带念珠菌的抗真菌活性的有效性。(2)方法:采用最低抑菌浓度(MIC)试验、棋盘试验和药敏片试验,检测壳聚糖与其他抗真菌药物联合应用对 和 的抑制作用。(3)结果:壳聚糖联合氟康唑治疗对 和 具有很强的协同杀菌作用,但同时联合应用壳聚糖-两性霉素 B 或壳聚糖-卡泊芬净对其抗真菌活性无影响。此外,壳聚糖和氟康唑联合使用对耐药菌株有效。(4)结论:这些发现为壳聚糖联合氟康唑治疗两种念珠菌及其耐药菌株提供了有力证据,表明这是一种很有前途的治疗方法。